{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:54:26Z","timestamp":1649138066898},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/bf03161200","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T12:20:52Z","timestamp":1251462052000},"page":"192-196","source":"Crossref","is-referenced-by-count":0,"title":["Case files of the University of Massachusetts Fellowship in Medical Toxicology: Lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin"],"prefix":"10.1007","volume":"4","author":[{"given":"James M.","family":"Courtney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03161200_CR1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0196-0644(83)80343-6","volume":"12","author":"KA Handal","year":"1983","unstructured":"Handal KA, Schauben JL, Salamone FR. Naloxone.Ann Emerg Med 1983; 12: 438\u2013445.","journal-title":"Ann Emerg Med"},{"key":"BF03161200_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/0003-4819-85-6-765","volume":"85","author":"WR Martin","year":"1976","unstructured":"Martin WR, Naloxone.Ann Intern Med 1976; 85: 765\u2013768.","journal-title":"Ann Intern Med"},{"key":"BF03161200_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/pr.57.2.5","volume":"57","author":"SM Foord","year":"2005","unstructured":"Foord SM, Bonner TI, Neubiq RR, Rosser EM, Pin JP, Davenport AP, et al. International Union of Pharmacology. XLVI. G protein-coupled receptor list.Pharmacol Rev 2005; 57: 279\u2013288.","journal-title":"Pharmacol Rev"},{"key":"BF03161200_CR4","first-page":"614","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"MA Howland","year":"2006","unstructured":"Howland MA. Antidotes in Depth\u2014Opioid Antagonists. 8th ed. Goldfrank\u2019s Toxicologic Emergencies. In: Flomenbaum NE, Goldfrank LR, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. 2006. New York: McGraw-Hill. 614\u2013619.","edition":"8th ed"},{"key":"BF03161200_CR5","first-page":"1726","volume":"38","author":"S Kim","year":"1997","unstructured":"Kim S, Wagner HN, Villemagne VL, Kao PF, Dannals RF, Ravert HT, et al. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.J Nucl Med 1997; 38: 1726\u20131731.","journal-title":"J Nucl Med"},{"key":"BF03161200_CR6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","volume":"44","author":"SH Ngai","year":"1976","unstructured":"Ngai SH, Berkowitz, BA, Yang JC, Hempstead J, Spector S. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.Anesthesiology 1976; 44: 398\u2013401.","journal-title":"Anesthesiology"},{"key":"BF03161200_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/j.1552-4604.1987.tb02191.x","volume":"27","author":"R Dixon","year":"1987","unstructured":"Dixon R, Gentile J, Hsu HB, Hsiao J, Howes J, Garg D, et al. Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist.J Clin Pharmacol 1987; 27: 233\u2013239.","journal-title":"J Clin Pharmacol"},{"key":"BF03161200_CR8","first-page":"273","volume":"3","author":"BL Crabtree","year":"1984","unstructured":"Crabtree BL. Review of naltrexone, a long-acting opiate antagonist.Clin Pharm 1984; 3: 273\u2013280.","journal-title":"Clin Pharm"},{"key":"BF03161200_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1213\/00000539-199403000-00021","volume":"78","author":"PS Glass","year":"1994","unstructured":"Glass PS, Jhaveri RM, Smith LR. Comparison of potency and duration of action of nalmefene and naloxone.Anesth Analg 1994; 78: 536\u2013541.","journal-title":"Anesth Analg"},{"key":"BF03161200_CR10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/j.1552-4604.1996.tb04179.x","volume":"36","author":"GR Matzke","year":"1996","unstructured":"Matzke GR, Frye RF, Alexander AC, Reynolds R, Dixon R, Johnston J, et al. The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene.J Clin Pharmacol 1996; 36: 144\u2013151.","journal-title":"J Clin Pharmacol"},{"key":"BF03161200_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004714-199202000-00008","volume":"12","author":"DA Chernik","year":"1992","unstructured":"Chernik DA, Tucker M, Gigli B, Yoo K, Paul K, Laine H, et al. Validity and reliability of the Neurobehavioral Assessment Scale.J Clin Psychopharmacol 1992; 12: 43\u201348.","journal-title":"J Clin Psychopharmacol"},{"key":"BF03161200_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0196-0644(99)70270-2","volume":"34","author":"JL Kaplan","year":"1999","unstructured":"Kaplan JL, Marx JA, Colabro JJ, Gin-Shaw SL, Spiller, JD, Spivey WL, et al. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.Ann Emerg Med 1999; 34: 42\u201350.","journal-title":"Ann Emerg Med"},{"key":"BF03161200_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0736-4679(98)00019-5","volume":"16","author":"DS Wang","year":"1998","unstructured":"Wang DS, Sternbach G, Varon J. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.J Emerg Med 1998; 16: 471\u2013475.","journal-title":"J Emerg Med"},{"key":"BF03161200_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0196-0644(86)80994-5","volume":"15","author":"L Goldfrank","year":"1986","unstructured":"Goldfrank L, Weisman RS, Errick JK, Lo MW. A dosing nomogram for continuous infusion intravenous naloxone.Ann Emerg Med 1986; 15: 566\u2013570.","journal-title":"Ann Emerg Med"},{"key":"BF03161200_CR15","first-page":"944","volume":"138","author":"JM Lewis","year":"1984","unstructured":"Lewis, JM, Klein-Schwartz W, Benson BE, Oderda GM, Takai S. Continuous naloxone infusion in pediatric narcotic overdose.Am J Dis Child 1984; 138: 944\u2013946.","journal-title":"Am J Dis Child"},{"key":"BF03161200_CR16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2710.2001.00380.x","volume":"26","author":"L Bernard","year":"2001","unstructured":"Bernard L, El-Hajj, Pron B, Lotth\u00e9 A, Gleizes V, Signoret F, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.J Clin Pharm Ther. 2001; 26: 445\u2013451.","journal-title":"J Clin Pharm Ther."},{"key":"BF03161200_CR17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/508456","volume":"43","author":"A Chary","year":"2006","unstructured":"Chary A, Tice AD, Martinelli LP, Liedtke LA, Plantenga MS, Strausbaugh LJ, et al. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.Clin Infect Dis 2006; 43: 1290\u20131295.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"BF03161200_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000048563","volume":"47","author":"AD Tice","year":"2001","unstructured":"Tice AD. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries.Chemotherapy 2001; 47 Suppl 1: 5\u201316.","journal-title":"Chemotherapy"},{"key":"BF03161200_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200018050-00004","volume":"18","author":"AO Wai","year":"2000","unstructured":"Wai AO, Frighetto L, Marra CA, Chan E, Jewesson PJ. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.Pharmacoeconomics 2000; 18: 451\u2013457.","journal-title":"Pharmacoeconomics"},{"key":"BF03161200_CR20","first-page":"320","volume":"46","author":"JW Kwan","year":"1989","unstructured":"Kwan JW. High-technology i.v. infusion devices.Am J Hosp Pharm 1989; 46: 320\u2013335.","journal-title":"Am J Hosp Pharm"},{"key":"BF03161200_CR21","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2146\/ajhp050408","volume":"63","author":"EA Skryabina","year":"2006","unstructured":"Skryabina EA, Dunn TS. Disposable infusion pumps.Am J Health Syst Pharm 2006; 63: 1260\u20131268.","journal-title":"Am J Health Syst Pharm"},{"key":"BF03161200_CR22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0140-6736(98)07115-3","volume":"352","author":"W Sneader","year":"1998","unstructured":"Sneader W. The discovery of heroin.Lancet 1998; 352: 1697\u20131699.","journal-title":"Lancet"},{"key":"BF03161200_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.forsciint.2006.02.009","volume":"164","author":"LR Odell","year":"2006","unstructured":"Odell LR, Skopec J, McCluskey A. A \u2018cold synthesis\u2019 of heroin and implications in heroin signature analysis utility of trifluoroacetic\/acetic anhydride in the acetylation of morphine.Forensic Sci Int 2006; 164: 221\u2013229.","journal-title":"Forensic Sci Int"},{"key":"BF03161200_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0379-0738(87)90074-0","volume":"34","author":"KR Bedford","year":"1987","unstructured":"Bedford KR, Nolan SL, Onrust R, Siegers JD. The illicit preparation of morphine and heroin from pharmaceutical products containing codeine: \u2018homebake\u2019 laboratories in New Zealand.Forensic Sci Int 1987; 34: 197\u2013204.","journal-title":"Forensic Sci Int"},{"key":"BF03161200_CR25","first-page":"590","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"LS Nelson","year":"2006","unstructured":"Nelson LS. Opioids. In: Flomenbaum NE, Goldfrank LR, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank\u2019s Toxicologic Emergencies. 8th ed. 2006. New York: McGraw-Hill. 590\u2013613.","edition":"8th ed"},{"key":"BF03161200_CR26","unstructured":"National Drug Intelligence Center: National Drug Threat Assessment 2005 Summary Report. February 2005. http:\/\/www. usdoj.gov\/ndic\/pubs11\/13846\/heroin.htm. Accessed 11\/23\/07."},{"key":"BF03161200_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","volume":"74","author":"CC Faura","year":"1998","unstructured":"Faura CC, Collins SL, Moore RA, McQuay HJ. Systematic review of factors affecting the ratios of morphine and its major metabolites.Pain 1998; 74: 43\u201353.","journal-title":"Pain"},{"key":"BF03161200_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","volume":"1","author":"EJ Rook","year":"2006","unstructured":"Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature.Curr Clin Pharmacol 2006; 1: 109\u2013118.","journal-title":"Curr Clin Pharmacol"},{"key":"BF03161200_CR29","first-page":"39","volume":"229","author":"JM Beaumont","year":"1982","unstructured":"Beaumont JM. Stability study of aqueous solutions of diamorphine and morphine using HPLC.Pharm J 1982; 229: 39\u201341.","journal-title":"Pharm J"},{"key":"BF03161200_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.2042-7158.1989.tb06452.x","volume":"41","author":"OA Omar","year":"1989","unstructured":"Omar OA, Hoskin, PJ, Johnston A, Hanks GW, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion.J Pharm Pharmacol 1989; 41: 275\u2013277.","journal-title":"J Pharm Pharmacol"},{"key":"BF03161200_CR31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.2042-7158.1992.tb05474.x","volume":"44","author":"DA Barrett","year":"1992","unstructured":"Barrett DA, Dyssegaard AL, Shaw PN. The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma.J Pharm Pharmacol 1992; 44: 606\u2013608.","journal-title":"J Pharm Pharmacol"},{"key":"BF03161200_CR32","first-page":"23","volume":"1","author":"MR Thomas","year":"2001","unstructured":"Thomas MR, Holquist C, Phillips J. Med error reports to FDA show a mixed bag.Drug Topics 2001;October 1: 23\u201324.","journal-title":"Drug Topics"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03161200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03161200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03161200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:36:29Z","timestamp":1558492589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03161200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["BF03161200"],"URL":"https:\/\/doi.org\/10.1007\/bf03161200","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}